BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10459284)

  • 21. A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer.
    Takeuchi S; Ohtsu A; Doi T; Kojima T; Minashi K; Mera K; Yano T; Tahara M; Muto M; Nihei K
    Am J Clin Oncol; 2007 Dec; 30(6):607-11. PubMed ID: 18091055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and toxicities of concurrent chemoradiation for elderly patients with esophageal cancer.
    Uno T; Isobe K; Kawakami H; Ueno N; Kobayashi H; Shimada H; Mastubara H; Okazumi S; Nabeya Y; Shiratori T; Ochiai T; Kawata T; Ito H
    Anticancer Res; 2004; 24(4):2483-6. PubMed ID: 15330202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemoradiotherapy].
    Ando N; Ozawa S; Kitagawa Y; Takeuchi H; Kitajima M
    Nihon Geka Gakkai Zasshi; 1997 Sep; 98(9):767-72. PubMed ID: 9370137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local or Metastatic Esophageal Cancer.
    Iwasaki K; Osaka Y; Tachibana S; Suda T; Ota Y; Hoshino S; Tsuchida A
    Anticancer Res; 2016 Mar; 36(3):987-94. PubMed ID: 26976988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The experience of concurrent radiotherapy and chemotherapy for advanced or recurrent esophageal cancers--continuous infusion of 5-FU and low dose cisplatin].
    Itoh Y; Kikuchi Y; Tenawa A; Muramoto H; Katoh E; Fuwa N
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1855-8. PubMed ID: 7574823
    [No Abstract]   [Full Text] [Related]  

  • 28. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.
    Seung SK; Smith JW; Molendyk J; Bader SB; Phillips M; Regan J; Louie J; Soo E; Seligman M; Ruzich J; Skokan L; Ross HJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):13-9. PubMed ID: 15726517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
    Maurel J; Cervantes A; Conill C; Salazar R; Martin-Richard M; Pera M; Manzano H; Chirivella I; Gallego R; Marfa X
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):91-6. PubMed ID: 15850907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment results of chemoradiation for T1 esophageal cancer with lymph node metastases.
    Itoh Y; Fuwa N; Matsumoto A; Asano A; Sasaoka M
    Radiat Med; 2000; 18(2):81-5. PubMed ID: 10888039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Concomitant radiotherapy and chemotherapy with protracted low dose continuous infusion of 5-fluorouracil and cisplatin].
    Sueyama H; Sakai K; Hasegawa M; Tsuchida E; Ito T; Sugita T; Higuchi S; Fujita K
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2839-41. PubMed ID: 7993125
    [No Abstract]   [Full Text] [Related]  

  • 33. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma.
    Kodaira T; Fuwa N; Kamata M; Furutani K; Tachibana H; Yamazaki T
    Anticancer Res; 2006; 26(1B):471-8. PubMed ID: 16739307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers].
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):933-8. PubMed ID: 10396320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
    Ando N; Ozawa S; Kitajima M; Iizuka T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):869-76. PubMed ID: 7540823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of complete response to esophageal cancer by a novel concurrent chemoradiation therapy.
    Shimoyama S; Aoki F; Kojima J; Kaminishi M
    Hepatogastroenterology; 1999; 46(28):2409-13. PubMed ID: 10522007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Low-dose FP therapy for advanced and recurrent gastric cancer].
    Yamashita Y; Ohira M; Sowa M; Shirasaka T; Hirakawa K; Chung YS
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1548-53. PubMed ID: 10553411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
    Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.